Clinically relevant interactions between newer antidepressants and second-generation antipsychotics

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.10, Iss.5, 2014-05, pp. : 721-746

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Clinically Significant Drug Interactions with Newer Antidepressants

By Spina Edoardo Trifirò Gianluca Caraci Filippo

CNS Drugs, Vol. 26, Iss. 1, 2012-01 ,pp. : 39-67

Adis International

Access to resources Recommend Favorite

Relationship between P-glycoprotein and second-generation antipsychotics

By Moons Tim de Roo Mariska Claes Stephan Dom Geert

Pharmacogenomics, Vol. 12, Iss. 8, 2011-08 ,pp. : 1193-1211

Future Medicine

Access to resources Recommend Favorite

Switching Between Second-Generation Antipsychotics: Why and How?

By Monika Edlinger Susanne Baumgartner Nadja Eltanaihi-Furtmüller Martina Hummer W. Wolfgang Fleischhacker

CNS Drugs, Vol. 19, Iss. 1, 2005-01 ,pp. : 27-42

Adis International

Access to resources Recommend Favorite

Newer, second-generation antipsychotics are prescribed for off-label indications far more often than first-generation antipsychotics in ordinary inpatient practice in Italy

Inpharma, Vol. 1, Iss. 1439, 2004-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Pharmacokinetic Drug Interactions Between Oral Contraceptives and Second-Generation Anticonvulsants

By Wilbur K.

Clinical Pharmacokinetics, Vol. 38, Iss. 4, 2000-04 ,pp. : 355-365

Adis International

Access to resources Recommend Favorite